Recruiting
Phase 1

LV20.19 & Pirtobrutinib

Sponsor:

Medical College of Wisconsin

Code:

NCT05990465

Conditions

Non Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Follicular Lymphoma

Marginal Zone Lymphoma

Mantle Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pirtobrutinib

LV20.19 CAR T cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Medical College of Wisconsin on 2025-02-19.